Number of Circulating CD14-Positive Cells and the Serum Levels of TNF-α Are Raised in Acute Charcot Foot
Author(s) -
Guillaume Mabilleau,
Nina L. Petrova,
Michael Edmonds,
A Sabokbar
Publication year - 2011
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc10-1695
Subject(s) - rankl , osteoclast , medicine , cd14 , bone resorption , multinucleate , diabetes mellitus , tumor necrosis factor alpha , receptor , activator (genetics) , endocrinology , immunology , pathology
Charcot neuro-osteoarthropathy (CNO) is a devastating complication of diabetes characterized by increased local bone resorption mediated by osteoclasts. Often CNO leads to multiple fractures and joint destruction resulting in severe deformity of the foot. Osteoclasts are multinucleated cells that have a common precursor with monocytes/macrophages (1). Previously, we reported that the number of osteoclasts generated in vitro from circulating cells was higher in acute CNO patients compared with diabetic control subjects and was partially independent from receptor activator for NF-κB (RANK)-RANK ligand (RANKL), the main osteoclastogenic mediator (2). One hypothesis could be that the number of circulating osteoclast precursors is increased in CNO. Among all monocytes subpopulations, CD14-positive cells are the most potent to transform into bone-resorbing osteoclasts (3).We studied 11 diabetic patients with recent onset of acute CNO, 10 diabetic …
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom